MedTrace Logo

Cataract Refractive Suite Study

NCT02974140 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2018-09-14

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the refractive predictability (prediction error) between the Cataract Refractive Suite (CRS) and standard manual technique at one month post-operative

Conditions

  • Cataracts

Interventions

DEVICE

Cataract Refractive Suite (CRS)

Configuration consisting of Verion™ Image Guided System, LenSx® Laser and ORA™ System with VerifEye+™ (with or without VerifEye Lynk), combined for use in surgical pre-op planning and during cataract surgery

PROCEDURE

Standard manual technique

Standard biometry for intra-ocular lens (IOL) calculation and cataract removal using phacoemulsification technique

Sponsors & Collaborators

  • Alcon, a Novartis Company

    lead INDUSTRY

Principal Investigators

  • Sr. Clinical Manager, GCRA · Alcon, A Novartis Division

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-02
Primary Completion
2017-07-25
Completion
2017-07-25
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02974140 on ClinicalTrials.gov